Neurostimulation: Vagus Nerve Stimulation and Beyond

Seminars in Pediatric Neurology

Volumn 18, Issue 3, 2011, Pages 186-194

  Kotagal, Prakash ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

BRAIN DEPTH STIMULATION; CENTRAL MEDIAN NUCLEUS; CEREBELLUM; COST EFFECTIVENESS ANALYSIS; COUGHING; DEVICE SAFETY; DRUG TREATMENT FAILURE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HOARSENESS; HUMAN; HYPERSALIVATION; INFECTION; INTRACTABLE EPILEPSY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SLEEP APNEA SYNDROME; SUBTHALAMIC NUCLEUS; THALAMUS ANTERIOR NUCLEUS; THALAMUS INTRALAMINAR NUCLEUS; THROAT DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE; VAGUS NERVE STIMULATION; VOCAL CORD DISORDER; BIOPHYSICS; BRAIN; EPILEPSY; METHODOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

BIOPHYSICS; BRAIN; DEEP BRAIN STIMULATION; EPILEPSY; HUMANS; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 80655125252     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2011.06.005     Document Type: Review

References (90)

1. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 2000, 342:314-319.
2. Beghi E. Accidents and injuries in patients with epilepsy. Expert Rev Neurother 2009, 9:291-298.
3. McGregor A., Wheless J., Baumgartner J., et al. Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans. Epilepsia 2005, 46:91-96.
4. Ben-Menachem E., Hamberger A., Hedner T., et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 1995, 20:221-227.
5. McLachlan R.S. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia 1993, 34:918-923.
6. Takaya M., Terry W.J., Naritoku D.K. Vagus nerve stimulation induces a sustained anticonvulsant effect. Epilepsia 1996, 37:1111-1116.
7. Koo B. EEG changes with vagus nerve stimulation. J Clin Neurophysiol 2001, 18:434-441.
8. Henry T.R., Bakay R.A., Votaw J.R., et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy. I. Acute effects at high and low levels of stimulation. Epilepsia 1998, 39:983-990.
9. Henry T.R., Votaw J.R., Pennell P.B., et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 1999, 52:1166-1173.
10. Marrosu F., Serra A., Maleci A., et al. Correlation between GABA (A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 2003, 55:59-70.
11. Conway C.R., Sheline Y.I., Chibnall J.T., et al. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res 2006, 146:179-184.
12. Asconapé J.J., Moore D.D., Zipes D.P., et al. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: A rare complication of intraoperative device testing. Epilepsia 1999, 40:1452-1454.
13. Ali I.I., Kanjwal Y., Wannamaker B., et al. Complete heart block with ventricular asystole during left vagus nerve stimulation for epilepsy. Epilepsy Behav 2004, 5:768-771. PNA.
14. Air E.L., Ghomri Y.M., Tyagi R., Grande A.W., et al. Management of vagal nerve stimulator infections: Do they need to be removed?. J Neurosurg Pediatr 2009, 3:73-78.
15. Kabir S.M., Rajaram C., Rittey C., et al. Vagus nerve stimulation in children with intractable epilepsy: Indications, complications and outcome. Childs Nerv Syst 2009, 25:1097-1100.
16. Khurana D.S., Reumann M., Hobdell E.F., et al. Vagus nerve stimulation in children with refractory epilepsy: Unusual complications and relationship to sleep-disordered breathing. Childs Nerv Syst 2007, 23:1309-1312.
17. Vonck K., Dedeurwaerdere S., De Groote L., et al. Generator replacement in epilepsy patients treated with vagus nerve stimulation. Seizure 2005, 14:89-99.
18. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002, 1:477-482.
19. Safety information 2007. Available at: Accessed July 10, 2011. http://mrisafety.com/safety_article.asp?subject=41.
20. Sucholeiki R., Alsaadi T.M., Morris G.L., et al. fMRI in patients implanted with a vagal nerve stimulator. Seizure 2002, 11:157-162.
21. Elliott R.E., Morsi A., Kalhorn S.P., et al. Vagus nerve stimulation in 436 patints consecutive patients with treatment-resistant epilepsy: Long-term outcomes and predictors of response. Epilepsy Behav 2011, 20:57-63.
22. Smyth M.D., Tubbs R.S., Bebin E.M., et al. Complications of chronic vagus nerve stimulation for epilepsy in children. J Neurosurg 2003, 99:200-203.
23. Wheless J.W. Vagus nerve stimulation therapy in pediatric patients: Use and effectiveness. Pediatric Epilepsy: Diagnosis and Therapy 2008, 811-827. Demos Medical. (ed 3). J.M. Pellock, B.F.D. Bourgeois, W.E. Dodson (Eds.).
24. Patwardhan R.V., Stong B., Bebin E.M., et al. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery 2000, 47:1357-1358.
25. Holmes M.D., Chang M., Kapur V. Sleep apnea and excessive daytime somnolence induced by vagal nerve stimulation. Neurology 2003, 61:1126-1129.
26. Hsieh T., Chen M., McAfee A., et al. Sleep-related breathing disorder in children with vagal nerve stimulators. Pediatr Neurol 2008, 38:99-103.
27. A randomized clinical trial of chronic vagus nerve stimulation for treatment of medically intractable epilepsy. Neurology 1995, 45:224-230. Vagus Nerve Stimulation Study Group.
28. Handforth A., DeGiorgio C.M., Schachter S.C., et al. Vagus nerve stimulation of partial-onset seizures: A randomized active-control trial. Neurology 1998, 51:48-55.
29. DeGiorgio C., Heck C., Bunch S., et al. Vagus nerve stimulation for epilepsy: Randomized comparison of three stimulation paradigms. Neurology 2005, 65:317-319.
30. Labiner D.M., Ahern G.L. Vagus nerve stimulation therapy in depression and epilepsy: Therapeutic parameter settings. Ann Neurol Scand 2007, 115:23-33.
31. Morris G.L. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy. Epilepsy Behav 2003, 4:740-745.
32. Helmers S.L., Wheless J.W., Frost M., et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: Retrospective study. J Child Neurol 2001, 16:843-848.
33. Murphy J.V., Torkelson R., Dowler I., et al. Vagal nerve stimulation in refractory epilepsy: The first 100 children receiving vagal nerve stimulation at a pediatric epilepsy center. Arch Pediatr Adolesc Med 2003, 157:560-564.
34. Shahwan A., Bailey C., Maxiner W., et al. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction. Epilepsia 2009, 50:1220-1228.
35. Alexopoulos A.V., Kotagal P., Loddenkemper T., et al. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006, 15:491-503.
36. Saneto R.P., Sotero de Menezes M.A., Ojemann J.G., et al. Vagus nerve stimulation for intractable seizures in children. Pediatr Neurol 2006, 35:323-326.
37. Janszky J., Hoppe M., Behne F., et al. Vagus nerve stimulation: Predictors of seizure freedom. J Neurol Neurosurg Psychiatry 2005, 76:384-389.
38. Ghaemi K., Elsharkawy A.E., Schulz R., et al. Vagus nerve stimulation: Outcome and predictors of seizure freedom in long-term follow-up. Seizure 2010, 19:264-268.
39. Wilfong A.A., Schultz R.J. Vagal nerve stimulation for the treatment of epilepsy in Rett syndrome. Dev Med Child Neurol 2006, 48:683-686.
40. Parain D., Peniello M.J., Berquen P., et al. Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 2001, 25:213-216.
41. Major P., Thiele E.A. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 2008, 13:357-360.
42. Elliott R.E., Carlson C., Kalhorn S.P., et al. Refractory epilepsy in tuberous sclerosis: Vagus nerve stimulation with or without subsequent resective surgery. Epilepsy Behav 2009, 16:454-460.
43. Parker A.P.J., Polkey C.E., Binnie C.D., et al. Vagal nerve stimulation in epileptic encephalopathies. Pediatrics 1999, 103:778-782.
44. Hallbook T., Lundgren J., Kohler S., et al. Beneficial effects of vagus nerve stimulation in children with therapy resistant epilepsy. Eur J Ped Neurol 2005, 9:399-407.
45. Kossoff E.H., Pyzik P.L., Rubenstein J.E., et al. Combined ketogenic diet and vagus nerve stimulation: Rational polytherapy?. Epilepsia 2007, 48:77-81.
46. You S.J., Kang H.C., Ko T.S., et al. Comparison of corpus callosotomy and vagus nerve stimulation in children with Lennox-Gastaut syndrome. Brain Dev 2008, 30:195-199., 2008.
47. Abd-El-Barr M.M., Joseph J.R., Schultz R., et al. Vagus nerve stimulation for drop attacks in a pediatric population. Epilepsy Behav 2010, 19:394-399.
48. Farrag A., Pestana E., Kotagal P. Vagal nerve stimulation for refractory absence seizures. Epilepsia 2002, 43(suppl 7):79-80.
49. Ng M., Devinsky O. Vagus nerve stimulation for refractory idiopathic generalized epilepsy. Seizure 2004, 13:176-178.
50. Hallbook T., Lundgren J., Stjernqvist K., et al. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure 2005, 14:504-513.
51. Hallbook T., Blennow G., Lundgren J., et al. Long term effects on epileptiform activity with vagus nerve stimulation in children. Seizure 2005, 14:527-533.
52. Kotagal P. Editorial comment: Can VNS therapy influence language and other cognitive functions?. Semin Pediatr Neurol 2010, 17:57-58.
53. Espinosa J., Aiello M.T., Naritoku D.K. Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator. Surg Neurol 1999, 51:659-664.
54. Boon P., D'Havé M., Van Walleghem P., et al. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: A prospective assessment. Epilepsia 2002, 43:96-102.
55. Ben-Menachem E., Hellstrom K., Verstappen D. Analysis of direct hospital costs before and after treatment with vagus nerve stimulation. Neurology 2002, 59:S44-S47.
56. Forbes R.B., Macdonald S., Eljamel S., et al. Cost utility analysis of vagus nerve stimulators for adults with medically refractory epilepsy. Seizure 2003, 12:49-54.
57. Forbes R. Cost-utility of vagus nerve stimulation (VNS) for medically refractory epilepsy-An update. Seizure 2008, 17:387-388.
58. Lozano A.M., Eltahawy H. How does DBS work?. Suppl Clin Neurophysiol 2004, 57:733-736.
59. Durand D. Electrical stimulation can inhibit synchronized neuronal activity. Brain Res 1986, 382:139-144.
60. Gluckman B.J., Neel E.J., Netoff T.I., et al. Electric field suppression of epileptiform activity in hippocampal slices. J Neurophysiol 1996, 76:4202-4205.
61. Cooper I.S., Amin I., Gilman S. The effect of chronic cerebellar stimulation upon epilepsy in man. Trans Am Neurol Assoc 1973, 98:192-196.
62. Cooper I.S., Amin I., Riklan M., et al. Chronic cerebellar stimulation in epilepsy. Clinical and anatomical studies. Arch Neurol 1976, 33:559-570.
63. Davis R., Gray E., Engle H., et al. Reduction of intractable seizures using cerebellar stimulation. Appl Neurophysiol 1983, 46:57-61.
64. Van Buren J.M., Wood J.H., Oakley J., et al. Preliminary evaluation of cerebellar stimulation by double blind stimulation and biological criteria in the treatment of epilepsy. J Neurosurg 1978, 48:407-416.
65. Wright G.D., McLellan D.L., Brice J.G. A double-blind trial of chronic cerebellar stimulation in twelve patients with severe epilepsy. J Neurol Neurosurg Psychiatry 1984, 47:769-774.
66. Velasco F., Carillo-Ruiz J.D., Brito F., et al. Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures. Epilepsia 2005, 46:1071-1081.
67. Depaulis A., Snead O.C., Marescaux C., et al. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 1989, 498:64-72.
68. Chabardès S., Kahane P., Minotti L., et al. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord 2002, 4(suppl 3):83-93.
69. Jasper H. Current evaluation of the concepts of centrencephalic and cortico-reticular seizures. Clin Neurophysiol 1991, 78:2-11.
70. Fisher R.S., Uematsu S., Krauss G.L., et al. Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia 1992, 33:841-851.
71. Velasco F., Velasco M., Jimenez F., et al. Stimulation of the central median nucleus for epilepsy. Stereotact Funct Neurosurg 2001, 77:228-232.
72. Cooper I.S., Upton A.R., Amin I., et al. Evoked metabolic responses in the limbic-striate system produced by stimulation of anterior nucleus of thalamus in man. Int J Neurol 1984, 18:179-187.
73. Mirski M.A., Ferendelli J.A. Interruption of the mamillothalamic tract prevents seizures in guinea pigs. Science 1984, 226:72-74.
74. Saillet S., Langlois M., Feddersen B., et al. Manipulating the epileptic brain using stimulation: A review of experimental studies. Epileptic Disord 2009, 11:100-112.
75. Fisher R., Salanova V., Witt T., et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010, 51:899-908. SANTE Study Group.
76. Salanova V., Fisher R. Long term efficacy of the SANTE trial (stimulation of the Anterior Nucleus of thalamus for epilepsy). Epilepsia 2010, (51). SANTE Study Group, (abstr 2.269). Available at: http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/Salanova/sy/2010/sb/All/id/12863. Accessed July 10, 2011.
77. Nakagawa M., Durand D. Suppression of spontaneous epileptiform activity with applied currents. Brain Res 1991, 567:241-247.
78. Psatta D.M. Control of chronic experimental focal epilepsy by feedback caudatum stimulations. Epilepsia 1983, 24:444-454.
79. Peters T.E., Bhavaraju N.C., Frei M.G., et al. Network system for automated seizure detection and contingent delivery of therapy. J Clin Neurophysiol 2001, 18:545-549.
80. Kossoff E.H., Ritzl E.K., Politsky J.M., et al. Effect of an external responsive neurostimulator on seizures and electrographic discharges during subdural electrode monitoring. Epilepsia 2004, 45:1560-1567.
81. Heck C. Epilepsia 2010, 51. RNS System Investigators, (abstr C.02), Accessed July 10, 2011. http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/Heck/sy/2010/sb/All/id/13411.
82. Krauss G. Responsive stimulation. Neurology Today January 6, 2011, 16-17.
83. Fregni F., Pascual-Leone A. Technology insight: Noninvasive brain stimulation in neurology-Perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 2007, 3:383-393.
84. Cincotta M., Borgheresi A., Gambetti C., et al. Suprathreshold 0.3Hz repetitive TMS prolongs the cortical silent period: Implications for therapeutic trials in epilepsy. Clin Neurophyiol 2003, 114:1827-1833.
85. Kimiskidis V.K. Transcranial magnetic stimulation for drug-resistant epilepsies: Rationale and clinical experience. Eur Neurol 2010, 63:205-210.
86. Tergau F., Neumann D., Rosenow F., et al. Can epilepsies be improved by repetitive transcranial magnetic stimulation?. Interim analysis of a controlled study. Clin Neurophysiol 2003, 56(suppl):400-405.
87. Fregni F., Otachi P.T.M., do Valle A., et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy. Ann Neurol 2006, 60:447-455.
88. Joo E.Y., Han S.J., Chung S.H., et al. Antiepileptic effects of low-frequency repetitive transcranial magnetic stimulation by different stimulation durations and locations. Clin Neurophysiol 2007, 118:702-708.
89. Cantello R., Rossi S., Varrasi C., et al. Slow repetitive TMS for drug-resistant epilepsy: Clinical and EEG findings of a placebo-controlled trial. Epilepsia 2007, 48:366-374.
90. Bae E.H., Schrader L.M., Machii K., et al. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: A review of the literature. Epilepsy Behav 2007, 10:521-528.